DPP4 and type 2 diabetes mellitus: For example, sitagliptin, a selective, potent dipeptidyl peptidase IV DPP-4 inhibitor, is the active ingredient in JANUVIA® and JANUMET® (a fixed dose combination with the antidiabetic agent metformin), which both recently received approval for the treatment of type 2 diabetes by the FDA [4].